TrialInternational urology and nephrology2014

Comparison between short- and long-acting erythropoiesis-stimulating agents in hemodialysis patients: target hemoglobin, variability, and outcome.

Bassam Bernieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.